Feb. 10, 2025
MONTPELLIER, FRANCE – Cilcare, a biotechnology company specializing in auditory sciences, has announced the launch of the SAPHIR study (early Stage of Alzheimer’s and Parkinson’s diseases, HearIng Relevance), an observational clinical study examining the relationship between hearing impairments and neurodegenerative diseases, particularly in the early stages of mild cognitive impairment (MCI) and Parkinson’s disease. Conducted in partnership with the University